PMID: 4357534Nov 1, 1973Paper

Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth

J H ClarkE J Peck


No abstract listed.


May 26, 1972·Biochemical and Biophysical Research Communications·H RochefortF Capony
Sep 26, 1972·Biochemical and Biophysical Research Communications·J N AndersonE J Peck
Oct 1, 1971·Biochemical and Biophysical Research Communications·D Williams, J Gorski
May 1, 1970·Acta Endocrinologica·L Terenius

❮ Previous
Next ❯


May 1, 1978·Arthritis and Rheumatism·M DuvicL W Klassen
Apr 13, 2001·Teratogenesis, Carcinogenesis, and Mutagenesis·T Nagao, S Yoshimura
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·S KallioR Toivola
Aug 15, 1982·Biochemical Pharmacology·W C ChangS I Murota
Apr 24, 1992·Brain Research·J M Gray, L Ziemian
Nov 1, 1976·Journal of Steroid Biochemistry·W L McGuireD T Zava
Jul 1, 1979·Journal of Steroid Biochemistry·T S RuhM F Ruh
Nov 1, 1979·Journal of Steroid Biochemistry·H RochefortM Garcia
Jan 1, 1980·Journal of Steroid Biochemistry·J H Clark, S A McCormack
Jan 1, 1980·Journal of Steroid Biochemistry·H RochefortB Westley
Dec 1, 1981·Journal of Steroid Biochemistry·D A Sullivan, C R Wira
Oct 1, 1988·Journal of Steroid Biochemistry·W L DuaxZ Wawrzak
Oct 1, 1988·Journal of Steroid Biochemistry·T C SpelsbergR Singh
Oct 1, 1988·Journal of Steroid Biochemistry·J R PasqualiniN Giambiagi
Aug 14, 1990·Journal of Steroid Biochemistry·C PasqualiniB Kerdelhué
Jul 3, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J BalaschJ A Vanrell
Aug 1, 1984·Physiology & Behavior·H B Ahdieh
Jan 1, 1981·Pharmacology & Therapeutics·J H Clark, B M Markaverich
Jan 1, 1983·Pharmacology & Therapeutics·G P ChrousosD L Loriaux
Jan 1, 1984·Pharmacology & Therapeutics·B J Furr, V C Jordan
Sep 1, 1975·Molecular and Cellular Endocrinology·F Capony, H Rochefort
Jul 1, 1977·Molecular and Cellular Endocrinology·F Capony, H Rochefort
Apr 1, 1977·Molecular and Cellular Endocrinology·V C JordanG Prestwich
Jul 1, 1978·Molecular and Cellular Endocrinology·F Capony, H Rochefort
Apr 1, 1981·Molecular and Cellular Endocrinology·L J BlackR L Goode
Jan 1, 1982·Molecular and Cellular Endocrinology·R L Sutherland, L C Murphy
Dec 19, 1979·Biochimica Et Biophysica Acta·D P EdwardsW L McGuire
Jan 1, 1984·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·M F RuhT S Ruh
Jun 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·G WangS R Glasser
Aug 4, 1975·Biochemical and Biophysical Research Communications·M Zan-Kowalczewska, J S Roth
Feb 27, 2001·Molecular and Cellular Endocrinology·M S CotroneoC A Lamartiniere

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.